CSL share price falls following acquisition chatter
CSL -2.5%: News overnight that CSL is apparently in talks to buy Swiss-based drug maker Vifor Pharma saw shares lower today.
CSL: +8.51%: A strong 1H22 for CSL relative to market expectations today plus their guidance was positive for the full year.
Read MoreCSL -2.5%: News overnight that CSL is apparently in talks to buy Swiss-based drug maker Vifor Pharma saw shares lower today.
CSL -1.47%: FY21 Result: A solid FY21 result for CSL booking a ~3% beat at the profit line.
A link to create a new password will be sent to the email address you have registered to your account.
Hi, this is only available to members. Join today and access the latest views on the latest developments from a professional money manager.
Our Smart Phone App will give you access to much of our content and notifications. Download for free today.